Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00224939 · ClinicalTrials.gov registry record · NA
Pre-ESRD Syndrome in High Risk African Americans
A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Terminated
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT00224939 is a NA study that was terminated before completion, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 144 participants.
The verdict
NCT00224939, a NA study, was terminated before completion, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- TERMINATED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.
Interventions
- DRUG Potassium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2002-07 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00224939
The ClinicalTrials.gov registry entry for NCT00224939 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Potassium Chloride is the first listed.
NCT00224939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00224939 about?
NCT00224939 is a clinical study titled "Pre-ESRD Syndrome in High Risk African Americans". Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.
What is the current status of trial NCT00224939?
This trial is currently terminated. It is a NA study. The enrollment target is 144 participants. The study started on 2002-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00224939?
The interventions under investigation include: Potassium Chloride (DRUG).
Who is sponsoring clinical trial NCT00224939?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.